New Hampshire Governor Kelly Ayotte vetoed Senate Bill 468, blocking a measure that would have allowed medical marijuana dispensaries to operate on-site greenhouses. Sponsors and backers framed the bill as a way to increase supply and reduce patient costs, while Ayotte said she opposed expanding cultivation in the state.
What the bill would do SB 468, sponsored by Sen. Howard Pearl (R-Loudon), would have permitted each licensed medical marijuana dispensary to maintain one on-site greenhouse for cultivation. The proposal applied to the state’s licensed “alternative treatment centers” and was limited to one greenhouse per dispensary.
Supporters argued the change would raise the state’s cannabis supply and put downward pressure on retail prices. New Hampshire currently restricts cannabis production to registered providers and limits patient possession to two ounces; supporters described SB 468 as a supply-side adjustment within that existing regulatory framework.
Governor’s reasoning for veto Ayotte issued a veto statement saying, “I do not support expanding the cultivation of marijuana in our state. For this reason, I have vetoed SB 468.” She has consistently opposed legalizing recreational cannabis in New Hampshire and cited several specific concerns in explaining her position on expanding cultivation: – Law enforcement limitations: Ayotte noted that current technology does not allow police to measure marijuana impairment in drivers the way breath alcohol tests measure blood alcohol concentration. She argued this gap complicates public-safety enforcement if more cannabis is cultivated or made widely available. – Youth mental health: Ayotte cited risks to adolescent mental health linked to increased cannabis availability. – Quality of life: She raised broader community impact concerns tied to wider cultivation and distribution.
Context: New Hampshire’s medical cannabis system New Hampshire legalized medical marijuana in 2013 under then-Governor Maggie Hassan. The state allows medical patients to possess up to two ounces and purchase from licensed alternative treatment centers (ATCs). At present, ATCs operate in seven towns: Chichester, Conway, Dover, Keene, Lebanon, Merrimack and Plymouth. Those centers are run by four nonprofit alternative treatment centers and require patients to present a physician-issued medical marijuana card to buy products.
New Hampshire remains the only New England state that has not legalized recreational cannabis. As of the veto, 24 U.S. states have legalized recreational cannabis and 39 allow medical cannabis in some form.
Legislative next steps Overriding Ayotte’s veto would require a two-thirds majority vote in both the New Hampshire House and Senate. Lawmakers plan to reconvene later this year to consider whether to attempt an override vote.
Other bills vetoed the same day Ayotte also vetoed two unrelated measures on the same day: – House Bill 1072, which would have required the state labor commissioner to give businesses 30 days’ advance notice before conducting inspections for potential misconduct. – House Bill 1643, which would have reduced the authority of guardian ad litems—family court officials who help parents resolve disputes over child custody and parenting plans.
Implications for patients and providers If SB 468 had become law, dispensaries running on-site greenhouses could have increased internal production capacity, potentially improving product availability for registered patients and lowering procurement costs for ATCs that now rely on external suppliers. Opponents of expanded cultivation argue that more local growing could make access easier for non-patients and complicate enforcement of possession limits. Ayotte’s veto maintains the current production model under which a limited number of nonprofit providers control supply and sales.
What advocates say Proponents of SB 468 framed the measure as a practical, limited change: one greenhouse per licensed dispensary, overseen by existing licensing rules. They said the change would directly address supply bottlenecks and high prices without broadening eligibility for medical cards or changing possession limits.
What critics say Critics, including Ayotte, pointed to public-safety and public-health risks they say would accompany expanded cultivation: harder-to-measure driving impairment, potential increases in youth access, and community-level impacts tied to more visible cultivation operations.
Bottom line Ayotte’s veto preserves New Hampshire’s current medical cannabis framework and keeps cultivation concentrated among the state’s licensed alternative treatment centers. The Legislature can attempt a two-thirds override when it reconvenes; otherwise, SB 468 will not take effect.
